Picropodophyllin

N/A

Report date: 2025/02/24 13:22:14
NME

Base Information

Drug NamePicropodophyllin
Drug Alias Name苦鬼臼脂素鬼臼苦素（Axelar）鬼臼毒素足叶苦素鬼柏苦 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin-like growth factor I receptor antagonists
TargetsInsulin-like growth factor I receptor
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungOligodendrogliomaGliosarcoma +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPakistan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAxelar Ab
China Registration ClassN/A

Develop Information

Active CompaniesSheikh Zayed Medical CollegeAxelar Ab
Inactive CompaniesRush University Medical Center
Active IndicationsCarcinoma, Non-Small-Cell LungAstrocytomaPapillomavirus Infections
Inactive IndicationsOligodendrogliomaGliosarcomaEpendymoma +[4] 

Other Information

ATC CodeN/A
Related LinksN/A